Amphastar Pharmaceuticals (AMPH) EBIT Margin Growth (1y) (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) EBIT Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 934.42 Mn | 644.30 Mn | 93.47 Mn | -258.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -258.00 |
| Mar 31, 2026 | -1,391.00 |
| Dec 31, 2025 | -476.00 |
| Sep 30, 2025 | -1,664.00 |
| Jun 30, 2025 | -609.00 |
| Mar 31, 2025 | -607.00 |
| Dec 31, 2024 | -611.00 |
| Sep 30, 2024 | -1,042.00 |
| Jun 30, 2024 | 495.00 |
| Mar 31, 2024 | 406.00 |
| Dec 31, 2023 | 229.00 |
| Sep 30, 2023 | 2,092.00 |
| Jun 30, 2023 | 522.00 |
| Mar 31, 2023 | 592.00 |
| Dec 31, 2022 | 796.00 |
| Sep 30, 2022 | -274.00 |
| Jun 30, 2022 | 972.00 |
| Mar 31, 2022 | 795.00 |
| Dec 31, 2021 | 1,706.00 |
| Sep 30, 2021 | 1,786.00 |